WebDeirdre Connelly, President, North America Pharmaceuticals, gave a presentation at the 2011 Annual Credit Suisse Healthcare Conference in Phoenix, AZ on 10 November. The presentation was attended by institutional investors and portfolio managers. Deirdre provided an overview of GSK’s US Pharmaceuticals business. WebJul 14, 2024 · GSK. Nov 2011 - Apr 20245 years 6 months. King of Prussia, PA. Co-program leader for five discovery programs spanning from target validation to candidate selection in a therapeutic agnostic group ...
100+ "Hilary Smith" profiles LinkedIn
WebApr 13, 2024 · The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain... WebGeneral medicines are usually prescribed in primary care or community settings by general healthcare practitioners. For us, this includes our medicines for inhaled respiratory, dermatology and other diseases. These vital medications are the engine room for GSK, supporting hundreds of millions of people to enjoy a better everyday quality of life. grant stone chelsea boots
Hilary Smith - Owner, Independent Stampin
WebThis paper describes GSK's approach to conducting clinical trials. It sets out the philosophy underpinning our approach and addresses issues including where we conduct our studies, the standard of care we apply and access to medicines post-trial. View policy position (PDF, 197.9KB) Cloning, genetic modification, and stem cell technologies WebLocations. You are currently visiting GSK Global. Learn more about GSK around the world by visiting our market websites. Our market company websites and web pages are intended for non-UK audiences. Content is provided for the home audience and may not align with UK regulations. Africa & Middle East Americas Asia Pacific Europe. WebGetting ahead of disease is one of the greatest, most inspiring challenges there is on the planet. By pursuing this purpose together, we have the scale and expertise to positively impact the health of 2.5 billion people in the next 10 years. In doing so, we will deliver stronger and more sustainable growth as a company where people can thrive. chip myers edward jones